Coloplast As Stock Story
| CLPBF Stock | USD 124.23 4.95 3.83% |
Roughly 62% of Coloplast's investor base is looking to short. The analysis of overall sentiment of trading Coloplast AS pink sheet suggests that many investors are alarmed at this time. Coloplast's investor sentiment overview provides quick insight into current market opportunities from investing in Coloplast AS. The current market sentiment, together with Coloplast's historical and current headlines, can help investors time the market. In addition, many technical investors use Coloplast AS stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Coloplast pink sheet news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Coloplast daily returns and investor perception about the current price of Coloplast AS as well as its diversification or hedging effects on your existing portfolios.
Coloplast |
Requested story not found. it has been either deleted or moved. View all stories for Coloplast AS.
Coloplast Latest Timeline
Coloplast is listed for 124.23. About 35.0% of the company shares are held by company insiders. The company last dividend was issued on the 2nd of December 2022. Coloplast AS had 5:1 split on the 19th of December 2012.Check out Coloplast Hype Analysis, Coloplast Correlation and Coloplast Performance. Note that the Coloplast AS information on this page should be used as a complementary analysis to other Coloplast's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.
Complementary Tools for Coloplast Pink Sheet analysis
When running Coloplast's price analysis, check to measure Coloplast's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Coloplast is operating at the current time. Most of Coloplast's value examination focuses on studying past and present price action to predict the probability of Coloplast's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Coloplast's price. Additionally, you may evaluate how the addition of Coloplast to your portfolios can decrease your overall portfolio volatility.
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |